Allscripts (NASDAQ: MDRX) reported Q1 EPS of $0.13, in-line with the analyst estimate of $0.13. Revenue for the quarter came in at $413 million versus the consensus estimate of $415.11 million.

Guidance:

Allscripts reaffirms its financial outlook for 2017, published originally on January 9, 2017:

1. Non-GAAP revenue of between $1.71 billion and $1.74 billion;
2. Adjusted EBITDA of between $345 million and $365 million, consisting of:
3. Allscripts, excluding Netsmart, Adjusted EBITDA of between $255 million and $265 million, and
4. Netsmart Adjusted EBITDA of between $90 million and $100 million; and
5. Non-GAAP earnings per share growth of between 10 to 15 percent

For earnings history and earnings-related data on Allscripts (MDRX) click here.